Conagen and Sumitomo Chemical, Japan's leading chemical company develop together p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis and polymerization.
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
01 août 2023 04h00 HE | Conagen
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan's leading chemical company, have announced to jointly develop...
Sweegen exhibits at Food Ingredients Europe 2022
Sweegen announces growth capital investments and manufacturing partnership ahead of Food Ingredients Europe 2022
05 déc. 2022 13h15 HE | Sweegen
Rancho Santa Margarita, Calif., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sweegen announced its strategic investment and partnership snapshot ahead of the FI Europe 2022, where it will exhibit zero sugar...
Conagen Receives a Strategic Investment from Sumitomo Chemical
31 mars 2020 15h51 HE | Conagen
Bedford, Mass., March 31, 2020 (GLOBE NEWSWIRE) -- Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan. The investment...
SWEEGEN RECEIVES STR
SWEEGEN RECEIVES STRATEGIC INVESTMENT FROM SUMITOMO CHEMICAL AND OUTLOOK INVESTMENT GROUP
08 oct. 2019 16h30 HE | SweeGen, Inc.
Rancho Santa Margarita, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- SweeGen, Inc., a stevia-based sweetener company has received an additional strategic investment from and led by Sumitomo Chemical, a...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...